Cargando…
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Recurrence is a serious problem in patients with bladder cancer. The hypothesis for recurrence was that the proliferation of drug-resistant cells was reported, and this study focused on drug resistance due to drug efflux. Previous studies have identified FOXM1 as the key gene for recurrence. We foun...
Autores principales: | Roh, Yun-Gil, Mun, Mi-Hye, Jeong, Mi-So, Kim, Won-Tae, Lee, Se-Ra, Chung, Jin-Woong, Kim, Seung Il, Kim, Tae Nam, Nam, Jong Kil, Leem, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836564/ https://www.ncbi.nlm.nih.gov/pubmed/29397866 http://dx.doi.org/10.5483/BMBRep.2018.51.2.222 |
Ejemplares similares
-
Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
por: Roh, Yun-Gil, et al.
Publicado: (2020) -
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
por: Kim, Min-Hye, et al.
Publicado: (2021) -
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
por: Mun, Jeong-Yeon, et al.
Publicado: (2022) -
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022) -
E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair
por: Mun, Jeong-Yeon, et al.
Publicado: (2020)